Indivior Newsroom

Piper Sandler Maintains Indivior(INDV.US) With Buy Rating, Maintains Target Price $16

Moomoo NewsDec 5 11:31 ET

Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating

Moomoo NewsNov 5 09:35 ET

Indivior Analyst Ratings

BenzingaOct 25 10:51 ET

Piper Sandler Maintains Indivior(INDV.US) With Buy Rating, Raises Target Price to $16

Moomoo NewsOct 25 08:37 ET

Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating

Moomoo NewsOct 24 09:34 ET

Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating

Moomoo NewsOct 23 09:31 ET

Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating

Moomoo NewsOct 22 09:34 ET

Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating

Moomoo NewsOct 21 09:35 ET

Analysts Offer Insights on Healthcare Companies: Indivior (GB:INDV), Vor Biopharma (VOR) and Allogene Therapeutics (ALLO)

TipRanksOct 15 05:03 ET

Stifel Maintains Indivior(INDV.US) With Buy Rating, Cuts Target Price to $18.98

Moomoo NewsOct 14 05:33 ET

Indivior Analyst Ratings

BenzingaOct 11 10:12 ET

Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating, Cuts Target Price to $16

Moomoo NewsOct 11 09:33 ET

Piper Sandler Maintains Indivior(INDV.US) With Buy Rating, Cuts Target Price to $15

Moomoo NewsOct 11 07:36 ET

Piper Sandler Remains a Buy on Indivior (INDV)

TipRanksOct 11 06:42 ET

Deutsche Bank Maintains Indivior(INDV.US) With Buy Rating, Cuts Target Price to $16.34

Moomoo NewsOct 11 06:36 ET

Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating

Moomoo NewsOct 8 09:31 ET

Craig-Hallum Maintains Indivior(INDV.US) With Buy Rating

Moomoo NewsSep 23 09:31 ET

Northland Securities Maintains Indivior(INDV.US) With Buy Rating, Cuts Target Price to $25

Moomoo NewsSep 17 09:33 ET

Indivior Analyst Ratings

BenzingaSep 13 11:35 ET

Piper Sandler Maintains Indivior(INDV.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsSep 13 07:33 ET